ezogabine has been researched along with ica 27243 in 9 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (ica 27243) | Trials (ica 27243) | Recent Studies (post-2010) (ica 27243) |
---|---|---|---|---|---|
383 | 26 | 241 | 17 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalby-Brown, W; Munro, G | 1 |
Bakshi, T; Bhamidipati, R; Brady, P; Cato, M; Chapman, M; Chaudhary, KW; Donovan, B; Dougherty, RW; Downie, D; Fu, T; Higgins, GA; Holenz, J; Kuppusamy, BM; Lin, H; Lluel, P; Madhyastha, N; Matsuoka, Y; Mohd, Z; Morrow, D; Pasikanti, K; Rajagopal, S; Rouget, C; Samanta, SK; Seefeld, MA; Zhen, W | 1 |
Nielsen, AN; Redrobe, JP | 1 |
Gerlach, AC; McCormack, K; Padilla, K; Wickenden, AD | 1 |
Blom, SM; Jensen, HS; Schmitt, N | 1 |
Hansen, HH; Kristensen, LV; Sandager-Nielsen, K | 2 |
Hansen, HH; Jensen, MM; Lange, SC; Mikkelsen, JD; Thomsen, MS | 1 |
Hayashi, H; Iwata, M; Matsumoto, T; Tsuchimori, N | 1 |
1 review(s) available for ezogabine and ica 27243
Article | Year |
---|---|
Kv7 (KCNQ) channel modulators and neuropathic pain.
Topics: Analgesics; Animals; Humans; Ion Channel Gating; KCNQ Potassium Channels; Pain; Peripheral Nervous System Diseases; Signal Transduction | 2007 |
8 other study(ies) available for ezogabine and ica 27243
Article | Year |
---|---|
Novel K
Topics: Animals; Anticonvulsants; Epilepsy; Humans; KCNQ Potassium Channels; Mice; Muscle Contraction; Muscle, Smooth; Protein Isoforms; Seizures; Urinary Bladder | 2018 |
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
Topics: Amphetamine; Animals; Anticonvulsants; Antimanic Agents; Benzamides; Bipolar Disorder; Carbamates; Central Nervous System Stimulants; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Indoles; Injections, Intraperitoneal; KCNQ Potassium Channels; Lamotrigine; Lithium Compounds; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenylenediamines; Pyridines; Triazines | 2009 |
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
Topics: Amino Acid Sequence; Animals; Anticonvulsants; Benzamides; Binding Sites; Carbamates; CHO Cells; Cricetinae; Cricetulus; Humans; KCNQ Potassium Channels; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Membrane Potentials; Membrane Transport Modulators; Molecular Sequence Data; Mutation; Phenylenediamines; Pyridines; Sequence Alignment; Tryptophan | 2009 |
Differential effects of ICA-27243 on cloned K(V)7 channels.
Topics: Animals; Benzamides; Binding Sites; Carbamates; Cells, Cultured; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Female; KCNQ Potassium Channels; KCNQ2 Potassium Channel; Membrane Potentials; Oocytes; Phenylenediamines; Pyridines; Rubidium Radioisotopes; Xenopus laevis | 2010 |
Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Body Temperature Regulation; Carbamates; Female; Hypothermia; Indoles; KCNQ Potassium Channels; Mice; Phenylenediamines; Protein Isoforms; Pyridines | 2011 |
The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Carbamates; Dopamine; Dopamine Antagonists; In Vitro Techniques; Indoles; Inhibitory Concentration 50; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mesencephalon; Neostriatum; Neurons; Nonlinear Dynamics; Phenylenediamines; Potassium Channel Blockers; Potassium Chloride; Pyridines; Rats; Rats, Wistar; Regression Analysis | 2011 |
K(v) 7 (KCNQ) channel openers normalize central 2-deoxyglucose uptake in a mouse model of mania and increase prefrontal cortical and hippocampal serine-9 phosphorylation levels of GSK3β.
Topics: Animals; Antimanic Agents; Autoradiography; Benzamides; Bipolar Disorder; Carbamates; Central Nervous System Stimulants; Chlordiazepoxide; Deoxyglucose; Dextroamphetamine; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypnotics and Sedatives; KCNQ Potassium Channels; Male; Mice; Mice, Inbred C57BL; Phenylenediamines; Phosphorylation; Prefrontal Cortex; Pyridines; Serine | 2012 |
Activation of peripheral KCNQ channels attenuates inflammatory pain.
Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Carbamates; Disease Models, Animal; Electric Stimulation; Exploratory Behavior; Formaldehyde; Freund's Adjuvant; Functional Laterality; Hyperalgesia; Inflammation; KCNQ Potassium Channels; Motor Skills Disorders; Pain; Pain Measurement; Pain Threshold; Phenylenediamines; Potassium Channel Blockers; Pyridines; Rats | 2014 |